Document is current
Any future updates will be listed below
-
Authors
Qi, Wei
Wang, Yuguang
Huang, Ying-Ying
Jiang, Yuxi
Yuan, Lintian
Lyu, Peijun
Arany, Praveen R
Hamblin, Michael R. https://orcid.org/0000-0001-6431-4605
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01AI050875)
- License Information
-
More Information
Article History
Received: 31 May 2019
Accepted: 23 September 2019
First Online: 17 December 2019
Compliance with ethical standards
:
: Michael R Hamblin declares the following potential conflicts of interest: Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH, USA; BeWell Global Inc, Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA, USA; LumiThera Inc, Poulsbo, WA, USA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA, USA; Global Photon Inc, Bee Cave, TX, USA; Medical Coherence, Boston MA, USA; NeuroThera, Newark DE, USA; JOOVV Inc, Minneapolis-St. Paul MN, USA; AIRx Medical, Pleasanton CA, USA; FIR Industries, Inc. Ramsey, NJ, USA; UVLRx Therapeutics, Oldsmar, FL, USA; Ultralux UV Inc, Lansing MI, USA; Illumiheal & Petthera, Shoreline, WA, USA; MB Lasertherapy, Houston, TX, USA; ARRC LED, San Clemente, CA, USA; Varuna Biomedical Corp. Incline Village, NV, USA; Niraxx Light Therapeutics, Inc, Boston, MA, USA. Consulting; Lexington Int, Boca Raton, FL, USA; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Eindhoven, Netherlands; Johnson & Johnson Inc, Philadelphia, PA, USA; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholdings: Global Photon Inc, Bee Cave, TX, USA; Mitonix, Newark, DE, USA. The other authors declare that they have no competing interest.
: Michael R Hamblin was funded by US NIH Grants R01AI050875 and R21AI121700. Yuguang Wang is funded by the following funds: The Clinical Characteristics Application of Research Projects in Capital (Z181100001718186), Smart Medical Discipline Construction Project in Peking University Health Science Center (BMU2018ZHYL013) and New Technology and New Therapy Project in Peking University School of Stomatology ( PKUSSNCT-16A06).
: The study was approved by the IRB of School and Hospital of Stomatology, Peking University, Beijing, China (PKUSSIRB-201728065), and all procedures were in accordance with the Declaration of Helsinki,
: Informed consent was obtained from all individual participants included in the study.
